Buch, Englisch, 294 Seiten, Format (B × H): 210 mm x 280 mm, Gewicht: 700 g
Buch, Englisch, 294 Seiten, Format (B × H): 210 mm x 280 mm, Gewicht: 700 g
ISBN: 978-1-032-34799-8
Verlag: Taylor & Francis
Coronaviruses can cause illness, severe disease, and death; for example, Middle East respiratory syndrome (MERS), severe acute respiratory syndrome (SARS), and COVID-19. Vaccine development and antiviral drugs are challenged by the propensity for viral mutations allowing these viruses to evade such therapies. There are a number of bioactive compounds from natural sources, which can exert health benefits and act as antiviral therapies such as anti-inflammation, antioxidative stress, and immune regulation. This book summarizes research on the potential efficacy and underlying mechanisms of bioactive compounds and traditional medicines against SARS-CoV-2.
Key Features
- Summarizes the potential benefits of bioactive therapies for coronaviruses
- Focuses on COVID-19, but also covers MERS and SARS
- Provides alternatives to vaccines and other antiviral drugs whose efficacy is reduced by viral mutations
- Relevant for clinicians and public health officials
Zielgruppe
Academic and Professional
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Immunologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Epidemiologie, Medizinische Statistik
- Naturwissenschaften Biowissenschaften Mikrobiologie
- Naturwissenschaften Biowissenschaften Biowissenschaften
Weitere Infos & Material
Chapter 1 - Omics-guided intervention strategies in combatting SARS-CoV-2: Recent advancements and challenges
Chapter 2 - The application of computer-aided drug design methods for developing natural compounds-based therapeutics against SARS-CoV-2
Chapter 3 - Therapeutic targets of host factors for potential COVID-19 treatments
Chapter 4 - Phytocompounds: A paradigm shift as therapeutics for COVID-19
Chapter 5 - Flavonoids as potential therapeutic agents against the SARS-CoV-2 infection: An overview
Chapter 6 - Antiviral activities of flavonoids against COVID-19 and other virus-causing ailments
Chapter 7 - Potential therapeutic effects of flavonoids against the COVID-19 infection: The mode of action
Chapter 8 - Terpene and Terpenoid: Potent antiviral agents against SARS-CoV-2
Chapter 9 - Phytonutrients and secondary metabolites to cease SARS-CoV-2 loop
Chapter 10 - Treatment strategies against COVID-19 using bioactive compounds and plant secondary metabolites
Chapter 11 - The potential contribution of vitamin K as a nutraceutical to scale down the mortality rate of COVID-19
Chapter 12 - Gastrointestinal Symptoms in COVID-19 patients: Prevention and Treatment
Chapter 13 - Mechanisms and management options of liver injury in COVID19: A Review
Chapter 14 - Marine species-derived bioactives against coronavirus disease
Chapter 15 - Potential bioactive compounds of Indian flora against SARS-CoV-2
Chapter 16 - Natural product-derived active compounds for the management of COVID-19: A summary from Indochina
Chapter 17 - Novel therapeutic strategy based on nanomedicine targeting thrombosis for SARSCoV-2
Chapter 18 - Nanomaterials in combating human coronavirus infections
Chapter 19 - Structural insights into drug targets from MERS, SARS-CoV, and SARS-CoV-2 and scope for phytochemicals as broad-spectrum anti-virals and immunomodulators.
Chapter 20 - Precision phytochemicals for COVID-19-induced olfactory dysfunction
